Azosemide (Standard)
Azosemide (Standard) is the analytical standard of Azosemide. This product is intended for research and analytical applications. Azosemide, a sulfonamide loop diuretic, is a potent NKCC1 inhibitor with IC50s of 0.246 μM and 0.197 μM for hNKCC1A and NKCC1B, respectively.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98%
- No. CAS: 27589-33-9
- Fòrmula: C12H11ClN6O2S2
- Peso molecular:370.84
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-107321
AzosemideNKCC1 Inhibitor -
HY-17468
BumetanideNKCC1 Inhibitor -
HY-17468R
Bumetanide (Standard)NKCC1 Inhibitor -
HY-B0135
FurosemideGABAA Receptor Antagonist -
HY-17468S
Bumetanide-d5NKCC1 Inhibitor -
HY-B0135R
Furosemide (Standard)Reference Standard -
HY-B0247
TorsemideDiuretic -
HY-B0135A
Furosemide sodiumGABAA Receptor Antagonist -
HY-119816
PiretanideDiuretic -
HY-B0247R
Torsemide (Standard) -
HY-119816R
Piretanide (Standard)Diuretic -
HY-B0135AR
Furosemide sodium (Standard)NKCC Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 27589-33-9
-
Peso molecular 370.84
-
Fòrmula C12H11ClN6O2S2
-
SMILES
ClC1=CC(NCC2=CC=CS2)=C(C3=NN=NN3)C=C1S(N)(=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Hampel P, et al. Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep. 2018 Jun 29;8(1):9877. [Content Brief]
[2]. Kim EJ, et al. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagaseanalbuminemic rats. Drug Metab Dispos. 2003 Feb;31(2):194-201. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Azosemide (Standard) Related Classifications
HY-107321R Related Classifications
Powered by Bioz